-
SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.AUD↓
1st Group Limited underperformed den DAX um -132 % vom 09.06.2015 bis 25.08.2021
Dir gefallen die Informationen zu 1st Group Limited?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:
Zu BUX Zero
Dir gefallen die Informationen zu 1st Group Limited?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:
Zur ING Diba
Dir gefallen die Informationen zu 1st Group Limited?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:
Zu Trade Republic
Dir gefallen die Informationen zu 1st Group Limited?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:
Zur Comdirect
20 News & Informationen zur 1st Group Limited Aktie
Check Up: Hexima roars 70pc on clinical trials, while Bionomics heads for a US dual listing
ASX 200 health stocks index is tracking the broader index well over the past two weeks. Both the XHJ Health Sector and the benchmark rose by 3%.
Futures Slide On Amazon Plunge, But World Markets Set For 6th Month Of Gains
ZeroHedge – On a long enough timeline, the survival rate for everyone drops to zero
ASX Small Cap Lunch Wrap: Who’s bringing some cases today?
ASX Small Cap Lunch Wrap: Who’s bringing some cases today?
4 things I’m looking for this reporting season
Another Australian reporting season is set to kick off tomorrow. Here are four things I'll be keeping an eye out for.
Commercial Property Investing & Auslink Property Trust
In this episode of The Australian Investors Podcast, I chat with Adam Bronts, director of business development at Castlerock. About his story and property fund, Castlerock's Auslink Property Trust No 1.
Kincora commences drilling at Fairholme Project
Kincora commences maiden drill program at the Fairholme Project to test the potential for 'Cowal-style' gold-base metal mineralization and to conf…
Check Up: Rhythm (ASX:RHY) plans US expansion, the US$1.5b dog dermatitis market and data dumps drive stocks down
Check Up: Rhythm (ASX:RHY) plans US expansion, the US$1.5b dog dermatitis market and data dumps drive stocks down
Julia Szlakowski sparked AMP's 'me too' moment, but it wasn't the first time she'd been forced out of a job due to sexual harassment
The woman whose complaint sparked the sexual harassment scandal that rocked AMP says years before her mistreatment at the financial services firm she was fired from another job for not sleeping with her boss.
ASX health stocks: AusCann (ASX:AC8) up 5pc after asking for approval of cannabis-based canine drug
ASX health stocks rose by 0.45% this morning. Medicinal cannabis company, AusCann (ASX:AC8), led the sector today, rising by 5% in morning trading.
Market Highlights and 5 ASX Small Caps to watch on Tuesday
ASX small caps to watch on Tuesday 20 July, and highlights from Wall Street overnight. ASX stocks include Mach7, eRoad, and EMVision.
These two ASX brain health stocks, boosted by FDA’s approval of Adulhelm, are kicking off clinical trials
ASX companies addressing brain health such as Actinogen (ASX:ACW) and HitIQ (ASX:HIQ) have never looked back from last month's landmark decision by the FDA.
Immutep Quarterly Activities Report
Immutep entered late-stage development in the newly validated LAG-3 space
Data from 1st line NSCLC and 2nd line HNSCC presented at ASCO
Efti to be
Exploration portfolio drilling update
Two rigs operational at the brownfield Trundle project: Deepest hole (TRDD022) completed to date at the Trundle Park prospect TRDD022 provides the…
Immutep Receives FDA And IRB Approval In The US For Phase IIb TACTI-003 Trial In HNSCC
Sydney, July 06, 2021 (GLOBE NEWSWIRE) — ASX/Media Release
Regulatory steps completed with the competent authority (FDA) and institutional review board
Asaleo Care : has become Essity
05 Jul 2021
Hygiene and health company Essity has finalised its acquisition of the remaining shares in Asaleo Care, as of July 1st, 2021. Essity is a leading global… | July 6, 2021
Dow Jones Steady as Tech Stocks Rally, Hang Seng May Rebound
The Dow Jones closed modestly higher after a lab report showed Modena’s Covid-19 vaccine is effective against the Delta strain. The Nasdaq 100 hit an all-time high. APAC markets may rebound.
Futures Rise To Record Despite Rising Delta Strain Jitters
ZeroHedge – On a long enough timeline, the survival rate for everyone drops to zero
Guy on Rocks: ‘The golden rule’ as Basel III takes effect
Guy on Rocks: ‘The golden rule’ as Basel III takes effect
Check Up: From Moderna’s effective jabs to Patrys’ brain cancer breakthrough
Stockhead reports ASX biotech and healthcare roundup for the last fortnight. Stocks include Actinogen (ACW), Suda Pharma (SUD), and Patrys (PAB).
Futures Steady Ahead Of Powell Testimony
ZeroHedge – On a long enough timeline, the survival rate for everyone drops to zero